Discontinued — last reported Q4 '25
Insmed Effect of Exchange Rate on Cash (Continuing Operations) decreased by 8000.0% to -$553.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 161.8%, from $895.00K to -$553.00K. Over 3 years (FY 2021 to FY 2025), Effect of Exchange Rate on Cash (Continuing Operations) shows an upward trend with a -0.1% CAGR.
A large negative value indicates a strengthening of the reporting currency against foreign holdings, while a positive value indicates the opposite.
The impact of fluctuations in foreign currency exchange rates on the company's cash and cash equivalent balances held in...
Standard disclosure for multinational corporations with significant international operations.
cvx_fx_effect_on_cash_continuing_operations| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$92.00K | -$461.00K | -$134.00K | -$969.00K | -$732.00K | $1.85M | -$1.14M | -$29.00K | -$3.40M | $2.17M | -$953.00K | -$688.00K | $1.84M | -$1.51M | $895.00K | $1.01M | -$976.00K | $7.00K | -$553.00K |
| QoQ Change | — | -401.1% | +70.9% | -623.1% | +24.5% | +352.6% | -161.9% | +97.5% | <-999% | +163.7% | -144.0% | +27.8% | +367.3% | -181.8% | +159.5% | +12.3% | -197.1% | +100.7% | <-999% |
| YoY Change | — | — | — | — | -695.7% | +501.1% | -753.7% | +97.0% | -364.9% | +17.3% | <-999% | +79.8% | -15.2% | — | +193.9% | +246.1% | -153.1% | +100.5% | -161.8% |